Exact Sciences Names Cologuard President
Exact Sciences named Mark Stenhouse as president of Cologuard, its noninvasive stool DNA-based test for early detection of colon cancer, the company announced recently. “More than 85 million people are…
Exact Sciences named Mark Stenhouse as president of Cologuard, its noninvasive stool DNA-based test for early detection of colon cancer, the company announced recently. “More than 85 million people are…
Exact Sciences named Paul J. Limburg, M.D., M.P.H., as its co-chief medical officer, the company announced today. “Dr. Limburg’s valuable mix of cancer prevention experience in both the clinical and…
Exact Sciences’ Cologuard has been used in more than one million screenings for colorectal cancer, the company announced today. “Approximately half of Cologuard users haven’t been screened before, and we’re…
Exact Sciences and the Urban League of Greater Madison (ULGM) have partnered to highlight how businesses and non-profit organizations can work together to strengthen the community, the organization announced recently. According…
Due to high Cologuard demand and a growing workforce, Exact Sciences announced recently it is building an additional facility at 650 Forward Dr. “Doctors and patients are increasingly choosing the convenience of…
Exact Sciences recently announced its second quarter numbers, which included revenue of $57.6 million and 135,000 completed Cologuard tests, an increase of 172 percent and 149 percent, respectively. “As patient and…
To help raise awareness of colon cancer and the importance of regular screening, professional golfer Jerry Kelly will wear a Cologuard-branded hat for the next two years, Exact Sciences announced…
Starting July 1, Exact Sciences’ Cologuard will be included for UnitedHealthcare members, the company announced recently. UnitedHealthcare’s network includes 1 million healthcare professionals and 6,000 hospitals across the United States….
The Centers for Medicare and Medicaid Services (CMS) is including Exact Sciences’ Cologuard in the 2018 Medicare Advantage Star Ratings program, the company announced recently. “We are pleased that Cologuard has…
A study by Exact Sciences and Mayo Clinic shows promise of a new blood-based lung cancer test, the organizations announced recently. “These results reveal an opportunity to detect lung cancer from…